Axcella Announces Upcoming Investor Conference Presentation
September 07 2021 - 7:58AM
Business Wire
H.C. Wainwright 23rd Annual Global Investment
Conference presentation and webcast to be available on September
13
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
pioneering a new approach to treat complex diseases and improve
health using endogenous metabolic modulator (EMM) compositions,
today announced that management will be presenting at the H.C.
Wainwright 23rd Annual Global Investment Conference.
A live audio webcast of this discussion will be available on the
“Investors & News” section of the company’s website,
www.axcellahealth.com, at 7:00 a.m. ET on September 13, 2021. A
replay will also be available on Axcella’s website for 90 days
following the presentation.
Internet Posting of Information
Axcella uses its website, www.axcellahealth.com, as a means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD. Such disclosures
will be included on the company’s website in the “Investors &
News” section. Accordingly, investors should monitor this portion
of the company’s website, in addition to its press releases, SEC
filings and public conference calls and webcasts.
About Axcella
Axcella is a clinical-stage biotechnology company pioneering a
new approach to treat complex diseases and improve health using
endogenous metabolic modulator (EMM) compositions. The company’s
product candidates are comprised of EMMs and their derivatives that
are engineered in distinct combinations and ratios to
simultaneously impact multiple biological pathways. Axcella’s
pipeline includes lead therapeutic candidates for the reduction in
risk of overt hepatic encephalopathy (OHE) recurrence and the
treatment of non-alcoholic steatohepatitis (NASH). For more
information, please visit www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210907005500/en/
Company Contact Jason Fredette
jfredette@axcellahealth.com 857.320.2236
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024